tirzepatide for sleep apnea covered by insurance FDA Approves First Drug Good news on the GLP-1

Zepbound was FDA-approved in November 2023 specifically for chronic weight management in adults with obesity or overweight and a related health condition

doi: 10.1073/pnas.1508836112 59 CassierEGallayNBourquardTClaeysenSBockaertJCrpieuxPet al

Any persistent mood symptoms warrant clinical assessment to rule out primary mental health conditions or other medical causes

High-fiber vegetables can worsen bloating initially, so it's important to reintroduce them carefully.

These spots, or macules, are often just extra melanin

High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners